The Journal of Practical Medicine ›› 2021, Vol. 37 ›› Issue (14): 1815-1819.doi: 10.3969/j.issn.1006⁃5725.2021.14.008

• Clinical Research • Previous Articles     Next Articles

Clinical study of platelet rich plasma in the treatment of flexor tendon stenosing tenosynovitis 

SUN Jin* WANG Wenxue,LI Xiao.   

  1. Department of Orthopedics,the Third Clinical Medical College of China Three Gorges Uni⁃ versity,Gezhouba Central Hospital of Sinopharm,Yichang 443002,China

  • Online:2021-07-25 Published:2021-07-25
  • Contact: LI Xiao E⁃mail:376940351@qq.om

Abstract:

Objective To explore the clinical effect of platelet rich plasma(Platelet rich plasma PRP)for the treatment of flexor tendon stenosing tenosynovitis. Methods From January 2017 to December 2019,65 patients with flexor tendon stenosing tenosynovitis were diagnosed and treated at our hospital using the random number table method,and were randomly divided into 32 cases in observation group and 33 cases in control group. The observa⁃ tion group received PRP injections,while the control group received triamcinolone acetonide injections. Before and after treatment,finger range of motion and visual analogue pain score(VAS),Quinnell score,total effective rate of treatment,and complications were assessed. Results There was no statistically significant difference in VAS Quinnell,or complications between the two groups before and after treatment(P > 0.05). At 4 and 8 weeks after treatment,the VAS,range of motion of finger joints,Quinnell score after treatment,and total effective rate were compared between the two groups,and the differences were statistically significant (P < 0.05). Conclusion Platelet rich plasma(PRP is an effective treatment for flexor tendon stenosing tenosynovitis,which can effectively alleviate the clinical symptoms,shorten the course of disease,and has no risk of complications. It is a treatment that should be promoted.

Key words:

platelet rich plasma, flexortendon, stenosing tenosynovitis, triamcinolone acetonide